Feasibility, safety, and efficacy of stereotactic body radiotherapy combined with intradermal heat-killed mycobacterium obuense (IMM-101) vaccination for non …
FR van't Land, D Latifi, M Moskie, MYV Homs… - Radiotherapy and …, 2023 - Elsevier
Background and purpose In this phase I/II trial, non-progressive locally advanced pancreatic
cancer (LAPC) patients after (modified) FOLFIRINOX therapy were treated with stereotactic …
cancer (LAPC) patients after (modified) FOLFIRINOX therapy were treated with stereotactic …
[PDF][PDF] Feasibilit, safet, and efficac of stereotactic bod radiotherap combined ith intradermal heat-killed m cobacterium obuense (IMM-101) accination for non-progressi …
WPCC SW - Radiotherapy and Oncology, 2023 - scholarlypublications …
abstract Background and purpose: In this phase I/II trial, non-progressive locally advanced
pancreatic cancer (LAPC) patients after (modified) FOLFIRINOX therapy were treated with …
pancreatic cancer (LAPC) patients after (modified) FOLFIRINOX therapy were treated with …